These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer. Kessous R; Octeau D; Klein K; Tonin PN; Greenwood CMT; Pelmus M; Laskov I; Kogan L; Salvador S; Lau S; Yasmeen A; Gotlieb WH Gynecol Oncol; 2018 Mar; 148(3):553-558. PubMed ID: 29395310 [TBL] [Abstract][Full Text] [Related]
10. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study. Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976 [TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of platinum-based chemotherapy in ovarian cancer patients with BRCA1/2 mutations]. Gorodnova TV; Maksimov SIa; Guseĭnov KD; Imianitov EN Vopr Onkol; 2014; 60(3):339-42. PubMed ID: 25033687 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer. Gorodnova TV; Kotiv KB; Ivantsov AO; Mikheyeva ON; Mikhailiuk GI; Lisyanskaya AS; Mikaya NA; Guseynov KD; Bondarev NE; Matveyeva NS; Nekrasova EA; Sidoruk AA; Roman LD; Manikhas GM; Belyaev AM; Sokolenko AP; Berlev IV; Imyanitov EN Int J Gynecol Cancer; 2018 Oct; 28(8):1498-1506. PubMed ID: 30247247 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor α-induced protein 8 expression as a predictor of prognosis and resistance in patients with advanced ovarian cancer treated with neoadjuvant chemotherapy. Wang J; Gao H; Liu G; Gu L; Yang C; Zhang F; Liu T Hum Pathol; 2018 Dec; 82():239-248. PubMed ID: 30107189 [TBL] [Abstract][Full Text] [Related]
14. Targeting DNA repair: the genome as a potential biomarker. Nesic K; Wakefield M; Kondrashova O; Scott CL; McNeish IA J Pathol; 2018 Apr; 244(5):586-597. PubMed ID: 29282716 [TBL] [Abstract][Full Text] [Related]
15. Addition of bevacizumab to neoadjuvant chemotherapy for Stage IV ovarian serous adenocarcinoma with multiple lymph node metastases: a case report. Liu H; Shi Y; Zhang GN; Song SQ; Hu T Eur J Gynaecol Oncol; 2015; 36(3):341-5. PubMed ID: 26189267 [TBL] [Abstract][Full Text] [Related]